INSMED (INSM) Covered Calls

INSMED covered calls Insmed Incorporated is a biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases and endocrine disorders within niche markets that have unmet medical needs.

You can sell covered calls on INSMED to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INSM (prices last updated Thu 4:16 PM ET):

INSMED (INSM) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
16.84 +0.18 16.35 17.71 767K - 1.3B
Covered Calls For INSMED (INSM)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 17 1.30 16.41 3.6% 35.5%
Jan 18 17 1.85 15.86 7.2% 40.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Insmed, Inc. operates as a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious lung diseases that are often life threatening. The company is focused on the development and commercialization of ARIKAYCE or liposomal amikacin for inhalation (LAI), for at least two identified orphan patient populations: patients with nontuberculous mycobacteria lung disease and cystic fibrosis patients with Pseudomonas aeruginosa lung infections. Its main product ARIKAYCE or LAI, is a once-a-day inhaled antibiotic treatment engineered to deliver an anti-infective directly to the site of serious lung infections. Insmed was founded on November 29, 1999 and is headquartered in Monmouth Junction, NJ.